Induction of immunotolerance via mPEG grafting to allogeneic leukocytes

Biomaterials

Volumn 32, Issue 35, 2011, Pages 9494-9503

  Wang, Duncheng ^a,c   Toyofuku, Wendy M ^a,c   Chen, Audrey M ^b   Scott, Mark D ^a,c  

^a CANADIAN BLOOD SERVICES   (Canada)

^b Moorpark College   (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Immunocamouflage; Lymphocyte; Poly(ethylene glycol); Regulatory T cells; Th17 lymphocytes; Tolerance

Indexed keywords

ETHYLENE; ETHYLENE GLYCOL; FITS AND TOLERANCES; GRAFTING (CHEMICAL); LYMPHOCYTES; POLYETHYLENE GLYCOLS; POLYOLS;

ALLOGENEIC CELLS; CELLS VIABILITIES; CONDITIONED MEDIAS; IMMUNOCAMOUFLAGE; IMMUNOMODULATORY EFFECTS; IMMUNOSUPPRESSIVE EFFECTS; INHIBITORY EFFECT; REGULATORY T CELLS;

T-CELLS;

GAMMA INTERFERON; INTERLEUKIN 2; MACROGOL; METHOXYPOLY(ETHYLENE GLYCOL); TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACUTE GRAFT REJECTION; ALLOGRAFT; ANIMAL CELL; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; ENGRAFTMENT; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; IN VIVO STUDY; LEUKOCYTE; LYMPHOCYTE; LYMPHOCYTE PROLIFERATION; MIXED LYMPHOCYTE REACTION; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SPLEEN CELL; TH17 CELL;

MURINAE; MUS;

EID: 80053590206     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.08.061     Document Type: Article

References (32)

1. Allison A.C. Immunosuppressive drugs: the first 50 years and a glance forward. Immunopharmacology 2000, 47:63-83.
2. Lacy P.E., Hegre O.D., Gerasimidi-Vazeou A., Gentile F.T., Dionne K.E. Maintenance of normoglycemia in diabetic mice by subcutaneous xenografts of encapsulated islets. Science 1991, 254:1782-1784.
3. Rathna G.V. Gelatin hydrogels: enhanced biocompatibility, drug release and cell viability. J Mater Sci Mater Med 2008, 19:2351-2358.
4. Sawhney A.S., Pathak C.P., Hubbell J.A. Modification of islet of langerhans surfaces with immunoprotective poly(ethylene glycol) coatings via interfacial photopolymerization. Biotechnol Bioeng 1994, 44:383-386.
5. Figliuzzi M., Plati T., Cornolti R., Adobati F., Fagiani A., Rossi L., et al. Biocompatibility and function of microencapsulated pancreatic islets. Acta Biomater 2006, 2:221-227.
6. Panza J.L., Wagner W.R., Rilo H.L., Rao R.H., Beckman E.J., Russell A.J. Treatment of rat pancreatic islets with reactive PEG. Biomaterials 2000, 21:1155-1164.
7. Scott M.D., Murad K.L., Koumpouras F., Talbot M., Eaton J.W. Chemical camouflage of antigenic determinants: stealth erythrocytes. Proc Natl Acad Sci U S A 1997, 94:7566-7571.
8. Murad K.L., Gosselin E.J., Eaton J.W., Scott M.D. Stealth cells: prevention of major histocompatibility complex class II-mediated T-cell activation by cell surface modification. Blood 1999, 94:2135-2141.
9. Murad K.L., Mahany K.L., Brugnara C., Kuypers F.A., Eaton J.W., Scott M.D. Structural and functional consequences of antigenic modulation of red blood cells with methoxypoly(ethylene glycol). Blood 1999, 93:2121-2127.
10. Bradley A.J., Test S.T., Murad K.L., Mitsuyoshi J., Scott M.D. Interactions of IgM ABO antibodies and complement with methoxy-PEG-modified human RBCs. Transfusion 2001, 41:1225-1233.
11. Chen A.M., Scott M.D. Current and future applications of immunological attenuation via pegylation of cells and tissue. BioDrugs 2001, 15:833-847.
12. Chen A.M., Scott M.D. Immunocamouflage: prevention of transfusion-induced graft-versus-host disease via polymer grafting of donor cells. J Biomed Mater Res A 2003, 67:626-636.
13. McCoy L.L., Scott M.D. Broad spectrum antiviral prophylaxis: inhibition of viral infection by polymer grafting with methoxypoly(ethylene glycol). Antiviral drug discovery for emerging diseases and bioterrorism threats 2005, 379-395. Wiley & Sons, Hoboken, NJ. T. PF (Ed.).
14. Chen A.M., Scott M.D. Comparative analysis of polymer and linker chemistries on the efficacy of immunocamouflage of murine leukocytes. Artif Cells Blood Substit Immobil Biotechnol 2006, 34:305-322.
15. Bradley A.J., Scott M.D. Immune complex binding by immunocamouflaged [poly(ethylene glycol)-grafted] erythrocytes. Am J Hematol 2007, 82:970-975.
16. Sutton T.C., Scott M.D. The effect of grafted methoxypoly(ethylene glycol) chain length on the inhibition of respiratory syncytial virus (RSV) infection and proliferation. Biomaterials 2010, 31:4223-4230.
17. Le Y., Scott M.D. Immunocamouflage: the biophysical basis of immunoprotection by grafted methoxypoly(ethylene glycol) [mpeg]. Acta Biomater 2010, 6:2631-2641.
18. Rossi N.A., Constantinescu I., Brooks D.E., Scott M.D., Kizhakkedathu J.N. Enhanced cell surface polymer grafting in concentrated and nonreactive aqueous polymer solutions. J Am Chem Soc 2010, 132:3423-3430.
19. Rossi N.A., Constantinescu I., Kainthan R.K., Brooks D.E., Scott M.D., Kizhakkedathu J.N. Red blood cell membrane grafting of multi-functional hyperbranched polyglycerols. Biomaterials 2010, 31:4167-4178.
20. Afzali B., Lombardi G., Lechler R.I., Lord G.M. The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin Exp Immunol 2007, 148:32-46.
21. Hanidziar D., Koulmanda M. Inflammation and the balance of Treg and Th17 cells in transplant rejection and tolerance. Curr Opin Organ Transplant 2010, 15:411-415.
22. Heidt S., Segundo D.S., Chadha R., Wood K.J. The impact of Th17 cells on transplant rejection and the induction of tolerance. Curr Opin Organ Transplant 2010, 15:456-461.
23. Mitchell P., Afzali B., Lombardi G., Lechler R.I. The T helper 17-regulatory T cell axis in transplant rejection and tolerance. Curr Opin Organ Transplant 2009, 14:326-331.
24. Weaver C.T., Hatton R.D. Interplay between the TH17 and TReg cell lineages: a (co-) evolutionary perspective. Nat Rev Immunol 2009, 9:883-889.
25. O'Neill D.W., Bhardwaj N. Differentiation of peripheral blood monocytes into dendritic cells. Curr Protoc Immunol 2005, Chapter 22: Unit 22F.4.
26. Bradley A.J., Murad K.L., Regan K.L., Scott M.D. Biophysical consequences of linker chemistry and polymer size on stealth erythrocytes: size does matter. Biochim Biophys Acta 2002, 1561:147-158.
27. Li J., Lai X., Liao W., He Y., Liu Y., Gong J. The dynamic changes of Th17/Treg cytokines in rat liver transplant rejection and tolerance. Int Immunopharmacol 2011, 11:962-967.
28. + regulatory T cells. Blood 2006, 107:1018-1023.
29. Lytton S.D., Berg U., Nemeth A., Ingelman-Sundberg M. Autoantibodies against cytochrome P450s in sera of children treated with immunosuppressive drugs. Clin Exp Immunol 2002, 127:293-302.
30. Abadja F., Videcoq C., Alamartine E., Berthoux F., Mariat C. Differential effect of cyclosporine and mycophenolic acid on the human regulatory T cells and TH-17 cells balance. Transplant Proc 2009, 41:3367-3370.
31. Pascual J., del Castillo D., Cabello M., Pallardo L., Grinyo J.M., Fernandez A.M., et al. Interaction between everolimus and tacrolimus in renal transplant recipients: a pharmacokinetic controlled trial. Transplantation 2010, 89:994-1000.
32. Noris M., Casiraghi F., Todeschini M., Cravedi P., Cugini D., Monteferrante G., et al. Regulatory T cells and T cell depletion: role of immunosuppressive drugs. J Am Soc Nephrol 2007, 18:1007-1018.